Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Crypto currencies is Beyond Innovation|Michael Wu,Founder and CEO,Amber Group
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Michael Wu is the Co-Founder and CEO of Amber Group.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Navigating the Best Offshore Havens: Insights on Corporate & Banking Choices | John Millar - Offshore Strategy Expert, GlobalBanks
00:10:00
AXA's Resilient Performance Amidst Geopolitical Uncertainty | Thomas Buberl, CEO , AXA Investment Managers.
00:10:00
Introduction to Social Enterprise: Legal Structures and Funding Strategies
00:10:00
Stone Harbor focuses on maintaining its coastal resilience and environmental preservation while managing community services. Key initiatives include beach nourishment projects, safeguarding beach-nesting birds, and ensuring the safety of the water supply.
00:10:00
Allosteric modulators for Human Health|TIM DYER,CEO,Addex Therapeutics Ltd
00:10:00
The Franco Regime: Legacy and Contemporary Perspectives|Stanley G. Payne,Professor,University of Wisconsin-Madison
00:00:00
Görgen Nilsson, CEO, ScandiDos
00:10:00
Perion Network (PERI) CEO Doron Gerstel dismisses industry challenges in an interview with Oliver.
00:10:00
New Centaur Resources' Awarmas Gold Project in Indonesia Overview
00:10:00
Carrie Hurihanganui on Auckland Airport's Tourism Revamp | Carrie Hurihanganui - CEO of auckland international airport ltd
00:10:00
Calibre Mining's Progress and Future Plans: An Interview with Dave at the One-to-One Conference in London
00:10:00
TradeFlow Capital Unveils Innovative, Multi-Channel Investment Products with Capital Protection and A-Rated Returns in Global Trade Finance|John Collis is Co-Founder, Chief Legal Officer (CLO), and Head of Compliance at TradeFlow